Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
GOLGA4-JAK2 fusion
i
Other names:
JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2, GOLGA4, Golgi Autoantigen, Golgin Subfamily A, 4, Golgin Subfamily A Member 4, Trans-Golgi P230, ProGolgin-240, Golgin-245, Centrosome-Related Protein F46, Golgin 245, CRPF46
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3717
;
2803
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
PAX5-JAK2 fusion (4)
PCM1-JAK2 fusion (2)
STRBP-JAK2 fusion (2)
ATF7IP-JAK2 fusion (1)
BCR-JAK2 fusion (1)
GOLGA5-JAK2 fusion (1)
JAK2 fusion (1)
ZEB2-JAK2 fusion (1)
GOLGA4-RAF1 fusion (1)
JAK2-ABL1 fusion (0)
PCM1-JAK2 fusion (0)
PAX5-JAK2 fusion (4)
PCM1-JAK2 fusion (2)
STRBP-JAK2 fusion (2)
ATF7IP-JAK2 fusion (1)
BCR-JAK2 fusion (1)
GOLGA5-JAK2 fusion (1)
JAK2 fusion (1)
ZEB2-JAK2 fusion (1)
GOLGA4-RAF1 fusion (1)
JAK2-ABL1 fusion (0)
PCM1-JAK2 fusion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
GOLGA4-JAK2 fusion
B Acute Lymphoblastic Leukemia
GOLGA4-JAK2 fusion
B Acute Lymphoblastic Leukemia
JAK inhibitor
Sensitive: D – Preclinical
JAK inhibitor
Sensitive
:
D
JAK inhibitor
Sensitive: D – Preclinical
JAK inhibitor
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.